Company / Share Buybacks
Cue Biopharma, Inc. Share Buybacks History
FY2019-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Share Buybacks
-
FY2023
5-year range
$0 / $750.1K
FY2019-FY2023
Trend
-100.0%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $750,128 to $0 over the past 2 years.
Share Buybacks over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, share buybacks decreased 100.0% year-over-year.
- Peak share buybacks was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -7.60 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Share BuybacksValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0 | -100.0% |
| FY2022 | $200.0K | -73.3% |
| FY2021 | $750.1K | +724.1% |
| FY2020 | $91.0K | +0.0% |
| FY2019 | $91.0K | - |
| FY2018 | - | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026